Riboswitches as Potential Targets for the Development of Anti-Biofilm Drugs.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Topics in Medicinal Chemistry

• Publication date

  2017-04-07

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/1568026617666170407163517PMID 28403796
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of a natural triple-tandem c-di-GMP riboswitch and application of the riboswitch-based dual-fluorescence reporter

  2016cited by this paper
• Cyclic di-GMP contributes to adaption and virulence of Bacillus thuringiensis through a riboswitch-regulated collagen adhesion protein

  2016cited by this paper
• Biofilm formation mechanisms and targets for developing antibiofilm agents.

  2015cited by this paper
• (Dis)similar Analogues of Riboswitch Metabolites as Antibacterial Lead Compounds.

  2015cited by this paper
• Novel Riboswitch-Binding Flavin Analog That Protects Mice against Clostridium difficile Infection without Inhibiting Cecal Flora

  2015cited by this paper
• Regulation of biofilm formation in Pseudomonas and Burkholderia species.

  2014cited by this paper
• E88, a new cyclic-di-GMP class I riboswitch aptamer from Clostridium tetani, has a similar fold to the prototypical class I riboswitch, Vc2, but differentially binds to c-di-GMP analogs.

  2014cited by this paper
• Cyclic Di-GMP Riboswitch-Regulated Type IV Pili Contribute to Aggregation of Clostridium difficile

  2014cited by this paper
• A disconnect between high-affinity binding and efficient regulation by antifolates and purines in the tetrahydrofolate riboswitch.

  2014cited by this paper
• Riboswitch-based antibacterial drug discovery using high-throughput screening methods

  2013cited by this paper
• Three-state mechanism couples ligand and temperature sensing in riboswitches

  2013cited by this paper
• Cyclic di-GMP: the First 25 Years of a Universal Bacterial Second Messenger

  2013cited by this paper
• Experimental treatment of Staphylococcus aureus bovine intramammary infection using a guanine riboswitch ligand analog.

  2013cited by this paper
• Synthesis and biological evaluation of a series of thieno-expanded tricyclic purine 2'-deoxy nucleoside analogues.

  2012cited by this paper
• Riboswitch control of Rho-dependent transcription termination

  2012cited by this paper
• Structural and biochemical characterization of linear dinucleotide analogues bound to the c-di-GMP-I aptamer.

  2012cited by this paper
• DDX41 recognizes bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response

  2012cited by this paper
• Endo-S-c-di-GMP Analogues-Polymorphism and Binding Studies with Class I Riboswitch

  2012cited by this paper
• Insights into the regulatory landscape of the lysine riboswitch.

  2012cited by this paper
• When the PilZ don't work: effectors for cyclic di-GMP action in bacteria.

  2012cited by this paper
• Identification of ligand analogues that control c-di-GMP riboswitches.

  2012cited by this paper
• 1-[2-(2-Benzoyl- and 2-benzylphenoxy)ethyl]uracils as potent anti-HIV-1 agents

  2011cited by this paper
• Conservative change to the phosphate moiety of cyclic diguanylic monophosphate remarkably affects its polymorphism and ability to bind DGC, PDE, and PilZ proteins.

  2011cited by this paper
• Purine and pyrimidine pathways as targets in Plasmodium falciparum.

  2011cited by this paper
• Riboswitches: discovery of drugs that target bacterial gene-regulatory RNAs.

  2011cited by this paper
• Prospects for riboswitch discovery and analysis.

  2011cited by this paper
• Mechanism for gene control by a natural allosteric group I ribozyme.

  2011cited by this paper
• Structural basis of differential ligand recognition by two classes of bis-(3′-5′)-cyclic dimeric guanosine monophosphate-binding riboswitches

  2011cited by this paper
• Differential analogue binding by two classes of c-di-GMP riboswitches.

  2011cited by this paper
• Carba-sugars activate the glmS-riboswitch of Staphylococcus aureus.

  2011cited by this paper
• Identification of novel ligands for thiamine pyrophosphate (TPP) riboswitches.

  2011cited by this paper
• Structural and biochemical determinants of ligand binding by the c-di-GMP riboswitch .

  2010cited by this paper
• Synthesis of cyclic di-nucleotidic acids as potential inhibitors targeting diguanylate cyclase.

  2010cited by this paper
• One-flask syntheses of c-di-GMP and the [Rp,Rp] and [Rp,Sp] thiophosphate analogues.

  2010cited by this paper
• Novel Riboswitch Ligand Analogs as Selective Inhibitors of Guanine-Related Metabolic Pathways

  2010cited by this paper
• Convenient synthesis of a propargylated cyclic (3'-5') diguanylic acid and its "click" conjugation to a biotinylated azide.

  2010cited by this paper
• Exploring Chemical Modifications for siRNA Therapeutics: A Structural and Functional Outlook

  2010cited by this paper
• An Allosteric Self-Splicing Ribozyme Triggered by a Bacterial Second Messenger

  2010cited by this paper
• Recognition of the bacterial second messenger cyclic diguanylate by its cognate riboswitch

  2009cited by this paper
• A variant riboswitch aptamer class for S-adenosylmethionine common in marine bacteria.

  2009cited by this paper
• Structural basis of ligand binding by a c-di-GMP riboswitch

  2009cited by this paper
• The structural and functional diversity of metabolite-binding riboswitches.

  2009cited by this paper
• Expanding roles for metabolite-sensing regulatory RNAs.

  2009cited by this paper
• LapD is a bis-(3′,5′)-cyclic dimeric GMP-binding protein that regulates surface attachment by Pseudomonas fluorescens Pf0–1

  2009cited by this paper
• Structural analysis of the GGDEF-EAL domain-containing c-di-GMP receptor FimX.

  2009cited by this paper
• Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression

  2009cited by this paper
• Design and antimicrobial action of purine analogues that bind Guanine riboswitches.

  2009cited by this paper
• Structural and mechanistic determinants of c-di-GMP signalling

  2009cited by this paper
• An expanded seed sequence definition accounts for full regulation of the hid 3' UTR by bantam miRNA.

  2009cited by this paper
• Signals, Regulatory Networks, and Materials That Build and Break Bacterial Biofilms

  2009cited by this paper
• Principles of c-di-GMP signalling in bacteria

  2009cited by this paper
• Regulatory RNAs in bacteria.

  2009cited by this paper
• S-box and T-box riboswitches and antisense RNA control a sulfur metabolic operon of Clostridium acetobutylicum

  2008cited by this paper
• Stereospecificity, substrate, and inhibitory properties of nucleoside diphosphate analogs for creatine and pyruvate kinases.

  2008cited by this paper
• A simple solid-phase synthesis of the ubiquitous bacterial signaling molecule, c-di-GMP and analogues.

  2008cited by this paper
• Biofilm development with an emphasis on Bacillus subtilis.

  2008cited by this paper
• A Molecular Clutch Disables Flagella in the Bacillus subtilis Biofilm

  2008cited by this paper
• Identification of FleQ from Pseudomonas aeruginosa as a c‐di‐GMP‐responsive transcription factor

  2008cited by this paper
• Artificial Riboswitches: Synthetic mRNA‐Based Regulators of Gene Expression

  2008cited by this paper
• Riboswitches in Eubacteria Sense the Second Messenger Cyclic Di-GMP

  2008cited by this paper
• Structural basis of thiamine pyrophosphate analogues binding to the eukaryotic riboswitch.

  2008cited by this paper
• A riboswitch selective for the queuosine precursor preQ1 contains an unusually small aptamer domain

  2007cited by this paper
• Identification of 22 candidate structured RNAs in bacteria using the CMfinder comparative genomics pipeline

  2007cited by this paper
• Ligand binding and gene control characteristics of tandem riboswitches in Bacillus anthracis.

  2007cited by this paper
• Stable analogues of aminoacyl-tRNA for inhibition of an essential step of bacterial cell-wall synthesis.

  2007cited by this paper
• Thiamine biosynthesis in algae is regulated by riboswitches

  2007cited by this paper
• Dispersing biofilms with engineered enzymatic bacteriophage

  2007cited by this paper
• Inhibitors of bacterial virulence identified in a surrogate host model

  2007cited by this paper
• The distributions, mechanisms, and structures of metabolite-binding riboswitches

  2007cited by this paper
• A cyclic-di-GMP receptor required for bacterial exopolysaccharide production

  2007cited by this paper
• The structural basis of cyclic diguanylate signal transduction by PilZ domains

  2007cited by this paper
• Mechanism of mRNA destabilization by the glmS ribozyme.

  2007cited by this paper
• Natural Variability in S-Adenosylmethionine (SAM)-Dependent Riboswitches: S-Box Elements in Bacillus subtilis Exhibit Differential Sensitivity to SAM In Vivo and In Vitro

  2007cited by this paper
• Health care-associated infections: major issues in the early years of the 21st century.

  2007cited by this paper
• Substrate specificity of Fpg (MutM) and hOGG1, two repair glycosylases.

  2007cited by this paper
• Antibacterial lysine analogs that target lysine riboswitches.

  2007cited by this paper
• Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media.

  2006cited by this paper
• Holding back the tide of antibiotic resistance.

  2006cited by this paper
• Crystal structures of the thi-box riboswitch bound to thiamine pyrophosphate analogs reveal adaptive RNA-small molecule recognition.

  2006cited by this paper
• Allosteric Control of Cyclic di-GMP Signaling*

  2006cited by this paper
• Identification of Helicobacter pylori biofilms in human gastric mucosa

  2006cited by this paper
• Mechanisms of cyclic-di-GMP signaling in bacteria.

  2006cited by this paper
• Riboswitches as antibacterial drug targets

  2006cited by this paper
• Structural basis for gene regulation by a thiamine pyrophosphate-sensing riboswitch

  2006cited by this paper
• Bacterial biofilms within the clinical setting: what healthcare professionals should know.

  2006cited by this paper
• Tandem Riboswitch Architectures Exhibit Complex Gene Control Functions

  2006cited by this paper
• Sampling the Antibiotic Resistome

  2006cited by this paper
• Identification and Characterization of a Cyclic di-GMP-specific Phosphodiesterase and Its Allosteric Control by GTP*

  2005cited by this paper
• Thiamine pyrophosphate riboswitches are targets for the antimicrobial compound pyrithiamine.

  2005cited by this paper
• C‐di‐GMP: the dawning of a novel bacterial signalling system

  2005cited by this paper
• Comparative genomics of the methionine metabolism in Gram-positive bacteria: a variety of regulatory systems.

  2004cited by this paper
• Cyclic di-GMP as a bacterial second messenger.

  2004cited by this paper
• Control of gene expression by a natural metabolite-responsive ribozyme

  2004cited by this paper
• A Glycine-Dependent Riboswitch That Uses Cooperative Binding to Control Gene Expression

  2004cited by this paper
• Structural basis of activity and allosteric control of diguanylate cyclase.

  2004cited by this paper
• Cell cycle-dependent dynamic localization of a bacterial response regulator with a novel di-guanylate cyclase output domain.

  2004cited by this paper
• Oligonucleotide incorporation of 8-thio-2'-deoxyguanosine.

  2004cited by this paper
• Riboflavin Production in Lactococcus lactis: Potential for In Situ Production of Vitamin-Enriched Foods

  2004cited by this paper
• What drives bacteria to produce a biofilm?

  2004cited by this paper
• Thiamine‐regulated gene expression of Aspergillus oryzae thiA requires splicing of the intron containing a riboswitch‐like domain in the 5′‐UTR

  2003cited by this paper

• Genome-Wide Computational Prediction and Analysis of Noncoding RNAs in Oleidesulfovibrio alaskensis G20

  2024cites this paper
• Current Strategies for Combating Biofilm-Forming Pathogens in Clinical Healthcare-Associated Infections

  2024cites this paper
• Antisense-acting riboswitches: A poorly characterized yet important model of transcriptional regulation in prokaryotic organisms

  2023cites this paper
• Real-time label-free detection of dynamic aptamer–small molecule interactions using a nanopore nucleic acid conformational sensor

  2023cites this paper
• Phenotypic and integrated analysis of a comprehensive Pseudomonas aeruginosa PAO1 library of mutants lacking cyclic-di-GMP-related genes

  2022cites this paper
• A systematic strategy for the investigation of vaccines and drugs targeting bacteria

  2020cites this paper
• A Glycine Riboswitch in Streptococcus pyogenes Controls Expression of a Sodium:Alanine Symporter Family Protein Gene

  2018cites this paper
• Riboswitches as Molecular Tools for Microbial Bioprospecting

  2018cites this paper
• Chronic tonsillitis and biofilms: a brief overview of treatment modalities

  2018cites this paper